CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
2.440
-0.130 (-5.06%)
At close: Apr 18, 2024, 4:00 PM
2.450
+0.010 (0.41%)
Pre-market: Apr 19, 2024, 7:20 AM EDT
CureVac Market Cap
CureVac has a market cap or net worth of $546.27 million as of April 19, 2024. Its market cap has decreased by -61.57% in one year.
Market Cap
546.27M
Enterprise Value
94.46M
1-Year Change
-61.57%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $2.82B to $546.27M, a decrease of -80.65%. That is a compound annual growth rate of -36.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2024 | 546.30M | -5.06% |
| Apr 17, 2024 | 575.40M | -3.55% |
| Apr 16, 2024 | 596.60M | 0.56% |
| Apr 15, 2024 | 593.30M | -8.93% |
| Apr 12, 2024 | 651.50M | -1.69% |
| Apr 11, 2024 | 662.70M | 0.33% |
| Apr 10, 2024 | 660.50M | -0.66% |
| Apr 9, 2024 | 664.90M | -3.26% |
| Apr 8, 2024 | 687.30M | 0.32% |
| Apr 5, 2024 | 685.10M | 3.38% |
| Apr 4, 2024 | 662.70M | 1.72% |
| Apr 3, 2024 | 651.50M | 1.04% |
| Apr 2, 2024 | 644.80M | -3.36% |
| Apr 1, 2024 | 667.20M | -1.65% |
| Mar 28, 2024 | 678.40M | -0.64% |
| Mar 27, 2024 | 682.80M | 3.74% |
| Mar 26, 2024 | 658.20M | -6.66% |
| Mar 25, 2024 | 705.20M | 3.28% |
| Mar 22, 2024 | 682.80M | 0.32% |
| Mar 21, 2024 | 680.60M | -0.32% |
| Mar 20, 2024 | 682.80M | 3.74% |
| Mar 19, 2024 | 658.20M | -8.42% |
| Mar 18, 2024 | 718.70M | -2.72% |
| Mar 15, 2024 | 738.80M | -0.90% |
| Mar 14, 2024 | 745.50M | -1.19% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 572.31M |
| Phathom Pharmaceuticals | 568.69M |
| Nuvation Bio | 567.46M |
| Mineralys Therapeutics | 564.80M |
| Applied Therapeutics | 563.21M |
| Olema Pharmaceuticals | 558.03M |
| AnaptysBio | 554.80M |
| Exscientia | 554.35M |